Samsung Medical Center
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
A Capsular Incision and Biochemical Recurrence After Radical Perineal Prostatectomy
- Conditions
- Radical Perineal Prostatectomy
- First Posted Date
- 2008-09-08
- Last Posted Date
- 2008-10-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 266
- Registration Number
- NCT00748514
- Locations
- 🇰🇷
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance Alone
- Conditions
- Coronary Artery Disease
- Interventions
- Procedure: The aggressive groupProcedure: The conservative group
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 899
- Registration Number
- NCT00743899
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis
- Conditions
- Colorectal CancerUnresectable Liver Metastasis
- Interventions
- Drug: FOLFOX6/cetuximab
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2013-06-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 73
- Registration Number
- NCT00743678
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
- Conditions
- Advanced Gastric Cancer
- Interventions
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2010-01-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 91
- Registration Number
- NCT00743964
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prospective Comparison of Immunological Benefit of Laparoscopic Colectomy
- Conditions
- Immunity
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2008-08-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 84
- Registration Number
- NCT00744159
- Locations
- 🇰🇷
Samsung Medical Center, Department of surgery, Seoul, Korea, Republic of
Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2010-08-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00730418
- Locations
- 🇰🇷
Samsung Medical Center, SEoul, Korea, Republic of
Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder
- Conditions
- Pain
- Interventions
- Device: repetitive Transcranial Magnetic Stimulation (rTMS)
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT00726791
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2013-06-10
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00687388
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female
- Conditions
- Voiding Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2013-06-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 190
- Registration Number
- NCT00679315
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
🇰🇷Holy Family Hospital, The Catholic University of Korea, Kyonggi-do, Korea, Republic of
🇰🇷Anam Hospital, College of Medicine, Korea University, Seoul, Korea, Republic of
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2008-05-14
- Last Posted Date
- 2013-06-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 344
- Registration Number
- NCT00677443
- Locations
- 🇰🇷
National Cancer Center, Goyang, Gyeonggi, Korea, Republic of
🇰🇷Chonnam National University Hospital, Hwasun, Jeollanamdo, Korea, Republic of
🇰🇷Gachon University Gil Medical Center, Inchon, Korea, Republic of